996 related articles for article (PubMed ID: 16034110)
1. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
[TBL] [Abstract][Full Text] [Related]
3. Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes.
Ehlers M; Laule-Kilian K; Petter M; Aldrian CJ; Grueter B; Würch A; Yoshida N; Watanabe T; Satake M; Steimle V
J Immunol; 2003 Oct; 171(7):3594-604. PubMed ID: 14500656
[TBL] [Abstract][Full Text] [Related]
4. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes.
Telfer JC; Hedblom EE; Anderson MK; Laurent MN; Rothenberg EV
J Immunol; 2004 Apr; 172(7):4359-70. PubMed ID: 15034051
[TBL] [Abstract][Full Text] [Related]
5. Analyzing expression of perforin, Runx3, and Thpok genes during positive selection reveals activation of CD8-differentiation programs by MHC II-signaled thymocytes.
Liu X; Taylor BJ; Sun G; Bosselut R
J Immunol; 2005 Oct; 175(7):4465-74. PubMed ID: 16177089
[TBL] [Abstract][Full Text] [Related]
6. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells.
Hayashi K; Natsume W; Watanabe T; Abe N; Iwai N; Okada H; Ito Y; Asano M; Iwakura Y; Habu S; Takahama Y; Satake M
J Immunol; 2000 Dec; 165(12):6816-24. PubMed ID: 11120804
[TBL] [Abstract][Full Text] [Related]
7. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
Urban JA; Winandy S
J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
[TBL] [Abstract][Full Text] [Related]
8. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.
Nawijn MC; Ferreira R; Dingjan GM; Kahre O; Drabek D; Karis A; Grosveld F; Hendriks RW
J Immunol; 2001 Jul; 167(2):715-23. PubMed ID: 11441075
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.
Taniuchi I; Osato M; Egawa T; Sunshine MJ; Bae SC; Komori T; Ito Y; Littman DR
Cell; 2002 Nov; 111(5):621-33. PubMed ID: 12464175
[TBL] [Abstract][Full Text] [Related]
10. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
Eshima K; Suzuki H; Shinohara N
J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
[TBL] [Abstract][Full Text] [Related]
12. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
Kwon H; Jun HS; Khil LY; Yoon JW
J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
[TBL] [Abstract][Full Text] [Related]
13. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
Xi H; Kersh GJ
J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
[TBL] [Abstract][Full Text] [Related]
14. Coreceptor signal strength regulates positive selection but does not determine CD4/CD8 lineage choice in a physiologic in vivo model.
Erman B; Alag AS; Dahle O; van Laethem F; Sarafova SD; Guinter TI; Sharrow SO; Grinberg A; Love PE; Singer A
J Immunol; 2006 Nov; 177(10):6613-25. PubMed ID: 17082573
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
[TBL] [Abstract][Full Text] [Related]
16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the expression of cKrox and Runx3, transcription regulatory factors controlling the lineage commitment of CD4+CD8+ into CD4 and CD8 thymocytes, respectively.
Gill BC; Jeon CH; Sung HN; Kim HL; Jin DW; Park JH
Toxicol Lett; 2008 Aug; 180(3):189-95. PubMed ID: 18602973
[TBL] [Abstract][Full Text] [Related]
17. Human CD4 expression at the late single-positive stage of thymic development supports T cell maturation and peripheral export in CD4-deficient mice.
Boyer O; Marodon G; Cohen JL; Lejeune L; Irinopoulou T; Liblau R; Bruneval P; Klatzmann D
J Immunol; 2002 Oct; 169(8):4347-53. PubMed ID: 12370367
[TBL] [Abstract][Full Text] [Related]
18. MAZR and Runx Factors Synergistically Repress ThPOK during CD8+ T Cell Lineage Development.
Sakaguchi S; Hainberger D; Tizian C; Tanaka H; Okuda T; Taniuchi I; Ellmeier W
J Immunol; 2015 Sep; 195(6):2879-87. PubMed ID: 26254341
[TBL] [Abstract][Full Text] [Related]
19. SRSF1 Deficiency Impairs the Late Thymocyte Maturation and the CD8 Single-Positive Lineage Fate Decision.
Ji C; Bao L; Yuan S; Qi Z; Wang F; You M; Yu G; Liu J; Cui X; Wang Z; Liu J; Guo W; Feng M; Chen F; Kang Y; Yu S
Front Immunol; 2022; 13():838719. PubMed ID: 35154164
[TBL] [Abstract][Full Text] [Related]
20. Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.
Xiong Y; Castro E; Yagi R; Zhu J; Lesourne R; Love PE; Feigenbaum L; Bosselut R
Eur J Immunol; 2013 Apr; 43(4):918-28. PubMed ID: 23310955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
